SCHEMBL7081808

SCHEMBL7081808

CC(C)(C)c1cc(-c2cc(O)cc(O)c2)ccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
ALOX15 P16050 2/20 0.61
CYP2C9 P11712 2/20 0.61
NR1I2 O75469 1/20 0.61
LMNA P02545 1/20 0.61
MIF P14174 1/20 0.61
TYR P14679 1/20 0.61
HTT P42858 1/20 0.61
NFE2L2 Q16236 1/20 0.61
HSD17B10 Q99714 1/20 0.61
RARB P10826 1/20 0.53
RARG P13631 1/20 0.53
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CYP1A2 P05177 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
ATP2A2 P16615 1/20 0.48
ATP2A3 Q93084 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31146788 0.89 ALDH1A1 (0.67) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL1176397 0.89 ALDH1A1 (0.67) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL1237149 0.86 ALDH1A1 (0.69) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL2721125 0.86 ALDH1A1 (0.69) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL7077598 0.84 ALDH1A1 (0.48) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL16581393 0.82 ALDH1A1 (0.57) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL8707369 0.80 ALDH1A1 (0.55) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL3565632 0.80 ALOX5 (0.57) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL7768449 0.78 ALDH1A1 (0.53) ALDH1A1ALOX15CYP2C9NR1I2LMNA
SCHEMBL2788496 0.78 ALDH1A1 (0.53) ALDH1A1ALOX15CYP2C9NR1I2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030139479-A1 Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same WARNER-LAMBERT COMPANY 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139479-A1 Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same AS3MT, PTPN1, NONO ALDH1A1 3382/4885ALOX15 1585/4885CYP2C9 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.